U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699016) titled 'Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery (HAEMOVAX)' on June 23.
Brief Summary: Hemostatic agents are widely used in cardiac and vascular surgery to support intraoperative bleeding control. Despite their clinical relevance and substantial economic impact, little is known about real-world patterns of use, adherence to evidence-based recommendations, and the alignment between clinicians' perceived knowledge and actual decision-making.
HAEMOVAX is a single-center mixed-methods observational study conducted at IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy. The study combines an anonymous survey of cardiov...